Recombinant Human Anti-CAMEL Soluble TCR (2/52) (ZIP-Fos/ZIP-Jun) (CAT#: VS-0622-YF59)
Human TCR (2/52) recognizes CAMEL peptide (aa 19-27 (AAQERRVPR)) in the context of HLA-DR. Soluble TCR expressed with ZIP-Fos/ZIP-Jun strategy (TRAV-TRAC partial-ZIP-Fos, TRBV-TRBC partial-ZIP-Jun) was validated to be able to bind pMHC in published references. The same expression strategy (ZIP-Fos/ZIP-Jun) is used to express this recombinant Human soluble TCR (2/52). Please note that the activity is not guaranteed.
Specific Inquiry
Subcellular Location
Normal Tissue
RNA Expression
Figure 1 IF staining of human cell line K-562
(Immunofluorescent staining of human cell line K-562 shows localization to nucleoplasm & vesicles.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/1854_C4_1_selected.jpg
(Immunofluorescent staining of human cell line K-562 shows localization to nucleoplasm & vesicles.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/1854_C4_1_selected.jpg
Figure 2 IF staining of human cell line K-562
(Immunofluorescent staining of human cell line K-562 shows localization to nucleoplasm, nuclear bodies & vesicles.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/76586/1854_F5_1_selected.jpg
(Immunofluorescent staining of human cell line K-562 shows localization to nucleoplasm, nuclear bodies & vesicles.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/76586/1854_F5_1_selected.jpg
Figure 3 Colon
(Glandular cells Staining: Low Intensity: Weak Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/156342_A_9_3.jpg
(Glandular cells Staining: Low Intensity: Weak Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/156342_A_9_3.jpg
Figure 4 Kidney
(Cells in tubules Staining: Low Intensity: Weak Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/156342_A_9_5.jpg
(Cells in tubules Staining: Low Intensity: Weak Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/156342_A_9_5.jpg
Figure 5 High expression in testis
(Elongated or late spermatids Staining: Medium Intensity: Moderate Quantity:>75% Leydig cells Staining: Low Intensity: Weak Quantity:>75% Pachytene spermatocytes Staining: Medium Intensity: Moderate Quantity:>75% Preleptotene spermatocytes Staining: High Intensity: Strong Quantity:>75% Round or early spermatids Staining: Medium Intensity: Moderate Quantity:>75% Spermatogonia cells Staining: High Intensity: Strong)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/156342_A_5_6.jpg
(Elongated or late spermatids Staining: Medium Intensity: Moderate Quantity:>75% Leydig cells Staining: Low Intensity: Weak Quantity:>75% Pachytene spermatocytes Staining: Medium Intensity: Moderate Quantity:>75% Preleptotene spermatocytes Staining: High Intensity: Strong Quantity:>75% Round or early spermatids Staining: Medium Intensity: Moderate Quantity:>75% Spermatogonia cells Staining: High Intensity: Strong)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/71467/156342_A_5_6.jpg
Figure 6 RNA cell line category: Cell line enhanced (GAMG, K-562, OE19, RPMI-8226, SK-BR-3, U-266/84)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000126890-CTAG2
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000126890-CTAG2
Specifications
- Host Species
- Human
- Target
- CAMEL
- Species Reactivity
- Human
- Epitope
- aa 19-27 (AAQERRVPR)
- MHC
- HLA-DR
- Clone
- 2/52
- Type
- Soluble TCR (ZIP-Fos/ZIP-Jun)
- Related Disease
- Cancer
- TCR Expression Strategy
- ZIP-Fos/ZIP-Jun strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on ZIP-Fox/ZIP-Jun. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- CTAG2; Cancer/testis antigen 2; CT2; ESO2; CAMEL; CT6.2; CT6.2a; CT6.2b; LAGE-1; LAGE2B
- Gene ID
- 30848
- UniProt ID
- O75638
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone 2/52"
See other products for "CTAG2"
Recombinant Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-3807z | Mouse Anti-CTAG2 Recombinant Antibody (clone 26H6) | WB, ELISA | Mouse IgG2b, κ |
| MOB-2016MZ | Recombinant Mouse Anti-Human CTAG2 Antibody | WB | Mouse antibody |
Rabbit Monoclonal Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOR-0851 | Hi-Affi™ Rabbit Anti-CTAG2 Recombinant Antibody (clone DS851AB) | WB | Rabbit IgG |
MHC Tetramer for Cancer
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MHC-CN0553 | PE-A*02:01/Human CTAG2 (MLMAQEALAFL) MHC Tetramer | FCM, IHC | |
| MHC-CN0554 | APC-A*02:01/Human CTAG2 (MLMAQEALAFL) MHC Tetramer | FCM, IHC | |
| MHC-CN0555 | FITC-A*02:01/Human CTAG2 (MLMAQEALAFL) MHC Tetramer | FCM, IHC | |
| MHC-CN0556 | A*02:01/Human CTAG2 (MLMAQEALAFL) MHC Tetramer | FCM, IHC | |
| MHC-CN0557 | PE-B*07:02/Human CTAG2 (APRGVRMAV) MHC Tetramer | FCM, IHC |
MHC Tetramer for Virology
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MHC-YF509 | A*02:01/HSV LANA-1 (QMARLAWEA) MHC Pentamer | FCM |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF59. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.